FDA-Inspected Site

Cellay, Inc

2 FDA inspections are on record for Cellay, Inc in Cambridge, United States.

483· Form 483 issued

Cambridge, United States · Last updated July 10, 2026

Overview

  • 2 FDA inspections are on record.
  • 1 inspection produced a Form 483.
  • The most recent recorded inspection date is 2016-02-10.

At a glance

Inspections

2

Form 483s

1

EIRs

0

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
29 Jan 2016 – 10 Feb 2016Medical Devices & Rad Health483View 483 →
18 Jun 2010Not recordedClean

Observations on record

Form 483 observations cited at this site, most recent first.

10 Feb 2016
21 CFR 806.10(a)(2)

Report of violation of the Act (see 803.52(e)(9))

Cited by James P Finn, Tamara S Rosbury

10 Feb 2016
21 CFR 820.100(a)

Lack of or inadequate procedures

Cited by James P Finn, Tamara S Rosbury

10 Feb 2016
21 CFR 820.198(a)

Lack of or inadequate complaint procedures

Cited by James P Finn, Tamara S Rosbury

10 Feb 2016
21 CFR 820.70(i)

Documentation of software validation

Cited by James P Finn, Tamara S Rosbury

10 Feb 2016
21 CFR 820.72(a)

Calibration, Inspection, etc. Procedures Lack of or Inadequ

Cited by James P Finn, Tamara S Rosbury

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 806.10(a)(2)Cited across public-safe Form 483 observations1x
21 CFR 820.100(a)Cited across public-safe Form 483 observations1x
21 CFR 820.198(a)Cited across public-safe Form 483 observations1x
21 CFR 820.70(i)Cited across public-safe Form 483 observations1x
21 CFR 820.72(a)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Cellay, Inc's 1 Form 483

Verbatim observations and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat